Literature DB >> 18623058

Flexible sigmoidoscopy and whole colonic imaging in the diagnosis of cancer in patients with colorectal symptoms.

M R Thompson1, K G Flashman, K Wooldrage, P A Rogers, A Senapati, D P O'Leary, W Atkin.   

Abstract

BACKGROUND: The aim was to identify the patients with colorectal symptoms most likely to benefit from whole colonic imaging (WCI) to diagnose colorectal cancer and those for whom flexible sigmoidoscopy (FS) may be initially sufficient.
METHODS: This prospective observational study (16 years) included 16 433 newly referred patients with symptoms or signs of colorectal cancer.
RESULTS: Colorectal cancer was diagnosed in 946 patients (diagnostic yield 5.8 per cent), 815 (86.2 per cent) in the rectum or sigmoid (distal) and 131 (13.8 per cent) in the proximal colon. Some 15 829 patients (96.3 per cent) presented with symptoms alone (without iron deficiency anaemia or abdominal mass). Of 787 cancers in these patients, 750 (95.3 per cent) were distal. The prevalence of proximal cancer above and below the age of 60 years was 0.4 per cent (33 of 8249) and 0.1 per cent (four of 7580) respectively. Of 16 256 patients having FS, 5665 (34.8 per cent) had WCI. Of the other 10 591, five subsequently presented with proximal cancers. FS missed ten (1.3 per cent) of 796 cancers.
CONCLUSION: Patients with iron deficiency anaemia or a mass require WCI. However, in patients with symptoms alone, FS detects 95 per cent of cancers, and the diagnostic yield of WCI after FS is very low. Alternative management strategies need to be developed to avoid unnecessary investigations in this low-risk group.

Entities:  

Mesh:

Year:  2008        PMID: 18623058     DOI: 10.1002/bjs.6234

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Quality assurance in flexible sigmoidoscopy: medical and nonmedical endoscopists.

Authors:  Sushil Maslekar; Philip Waudby; Ged Avery; J R T Monson; Graeme Scott Duthie
Journal:  Surg Endosc       Date:  2009-08-18       Impact factor: 4.584

Review 2.  Guideline for referral of patients with suspected colorectal cancer by family physicians and other primary care providers.

Authors:  M Elisabeth Del Giudice; Emily T Vella; Amanda Hey; Marko Simunovic; William Harris; Cheryl Levitt
Journal:  Can Fam Physician       Date:  2014-08       Impact factor: 3.275

3.  Delayed diagnosis of familial adenomatous polyposis in an adolescent patient with a coexisting eating disorder.

Authors:  Wu Deng; Steve Sears; Susan Garand; Laurie Farricielli
Journal:  BMJ Case Rep       Date:  2013-12-11

4.  Safe investigation of isolated change in bowel habit with a flexible sigmoidoscopy? A systematic review and meta-analysis.

Authors:  Pjj Herrod; H Boyd-Carson; B Doleman; Jem Blackwell; Ejo Hardy; F Harper; J N Lund
Journal:  Ann R Coll Surg Engl       Date:  2019-03-11       Impact factor: 1.891

Review 5.  Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis.

Authors:  Petra Jellema; Daniëlle A W M van der Windt; David J Bruinvels; Christian D Mallen; Stijn J B van Weyenberg; Chris J Mulder; Henrica C W de Vet
Journal:  BMJ       Date:  2010-03-31

6.  Whole-colon investigation vs. flexible sigmoidoscopy for suspected colorectal cancer based on presenting symptoms and signs: a multicentre cohort study.

Authors:  Amanda J Cross; Kate Wooldrage; Emma C Robbins; Kevin Pack; Jeremy P Brown; William Hamilton; Michael R Thompson; Karen G Flashman; Steve Halligan; Siwan Thomas-Gibson; Margaret Vance; Brian P Saunders; Wendy Atkin
Journal:  Br J Cancer       Date:  2018-12-19       Impact factor: 7.640

7.  Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.

Authors:  C Chapman; J Bunce; S Oliver; O Ng; A Tangri; R Rogers; R F Logan; D J Humes; A Banerjea
Journal:  BJS Open       Date:  2019-01-28

8.  Anaemia as a risk stratification tool for symptomatic patients referred via the two-week wait pathway for colorectal cancer.

Authors:  S Mashlab; P Large; W Laing; O Ng; M D'Auria; D Thurston; S Thomson; A G Acheson; D J Humes; A Banerjea
Journal:  Ann R Coll Surg Engl       Date:  2018-03-15       Impact factor: 1.891

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.